Diagnosis of life-threatening deep-seated infections currently requires invasive sampling of the infected tissue to provide a microbiologic diagnosis. These procedures can lead to high morbidity in patients and add to healthcare costs. Here we describe a novel next-generation sequencing assay that was used to detect pathogen-derived cell-free DNA in peripheral blood of patients with biopsy-proven invasive fungal infections. The noninvasive nature of this approach could provide rapid, actionable treatment information for invasive fungal infections when a biopsy is not possible.
Keywords: Diagnostic biopsy; Invasive fungal infection; Molecular diagnostics; Next-generation sequencing; Noninvasive.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.